Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

BACKGROUND: Maraviroc-containing combined antiretroviral therapy (MVC-cART) improved the response to the hepatitis B virus (HBV) vaccine in HIV-infected subjects younger than 50 years old. We aimed here to explore the effect of this antiretroviral therapy on different immunological parameters that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrero-Fernández, Inés, Rosado-Sánchez, Isaac, Genebat, Miguel, Tarancón-Díez, Laura, Rodríguez-Méndez, María Mar, Pozo-Balado, María Mar, Lozano, Carmen, Ruiz-Mateos, Ezequiel, Leal, Manuel, Pacheco, Yolanda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116502/
https://www.ncbi.nlm.nih.gov/pubmed/30157873
http://dx.doi.org/10.1186/s12967-018-1617-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116502/
https://www.ncbi.nlm.nih.gov/pubmed/30157873
http://dx.doi.org/10.1186/s12967-018-1617-1

Ejemplares similares